Arthur Kaser

Arthur Kaser

Auto-generated profile, based on publicly available information

Arthur Kaser

University Hospital Innsbruck, Department of Medicine, Division of Gastroenterology and Hepatology, University Hospital Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2011 in Gut
Verified
Journal Article
Open access
PDF file
TFTeresa Fritz
Teresa Fritz
LNLukas Niederreiter
Lukas Niederreiter
TATimon Adolph
Timon Adolph
RBRichard S Blumberg
Richard S Blumberg
AKArthur Kaser
Arthur Kaser
Polymorphisms in NOD2, encoding an intracellular pattern recognition receptor, contribute the largest fraction of genetic risk for Crohn's disease among the >40 risk loci identified so far. Autophagy plays a prominent role in the innate immune response towards intracellular bacteria. The discovery of the autophagy genes ATG16L1 and IRGM as risk factors for Crohn's disease turned autophagy into the spotlight in inflammatory bowel disease (IBD). Remarkably, NOD2 has recently been identified as a potent autophagy inducer. A physical interaction of NOD2 and ATG16L1 appears to be required for autophagic clearance of intracellular pathogens. Moreover, Crohn's disease-associated NOD2 and ATG16L1 variants exhibit a defect in the induction of an autophagic response and hence predict autophagy as a key converging mechanism that leads to Crohn's disease. Another pathway that is closely intertwined with autophagy and mutually cross-regulated is the unfolded protein response (UPR), which is induced by endoplasmic reticulum (ER) stress. Genes involved in the UPR (XBP1, ORMDL3) have also been genetically associated with Crohn's disease and ulcerative colitis. Moreover, the intestinal epithelium at the interface between host and microbe appears particularly affected by IBD-associated hypomorphic function of autophagy and the UPR. The functional convergence of main genetic risk factors for IBD on these innate immune pathways has hence important implications for the host's interaction with the microbiota. Moreover, the genetic convergence on these molecular mechanisms may open novel therapeutic options for IBD that deserve further exploration.

3 May 2010 in Cell Research
Verified
Journal Article
Open access
PDF file
AKArthur Kaser
Arthur Kaser
RBRichard S Blumberg
Richard S Blumberg
Ron D, Walter P . Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007; 8:519–529. CAS Article PubMed Google Scholar Richardson CE, Kooistra T, Kim DH . An essential role for XBP-1 in host protection against immune activation in C. elegans. Nature 2010; 463:1092–1095. CAS Article PubMed PubMed Central Google Scholar Kim DH, Feinbaum R, Alloing G, et al. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 2002; 297:623–626. CAS Article PubMed Google Scholar Troemel ER, Chu SW, Reinke V, Lee SS, Ausubel FM, Kim DH . p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet 2006; 2:e183. Article PubMed PubMed Central Google Scholar Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008; 134:743–756. CAS Article PubMed PubMed Central Google Scholar Salzman NH, Hung K, Haribhai D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010; 11:76–83. CAS Article PubMed Google Scholar Zheng W, Rosenstiel P, Huse K, et al. Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun 2006; 7:11–18. CAS Article PubMed Google Scholar Zhao F, Edwards R, Dizon D, et al. Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-/-mice. Dev Biol 2010; 338:270–279. CAS Article PubMed Google Scholar Zhang FR, Huang W, Chen SM, et al. Genomewide association study of leprosy. N Engl J Med 2009; 361:2609–2618. CAS Article PubMed PubMed Central Google Scholar Iwakoshi NN, Pypaert M, Glimcher LH . The transcription factor XBP-1 is essential for the development and survival of dendritic cells. J Exp Med 2007; 204:2267–2275. CAS Article PubMed PubMed Central Google Scholar Woo CW, Cui D, Arellano J, et al. Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling. Nat Cell Biol 2009; 11:1473–1480. CAS Article PubMed PubMed Central Google Scholar Iwakoshi NN, Lee AH, Vallabhajosyula P, Otipoby KL, Rajewsky K, Glimcher LH . Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol 2003; 4:321–329. CAS Article PubMed Google Scholar Download references Department of Medicine II, Innsbruck Medical University, Anichstrasse 35, A-6020, Innsbruck, Austria Arthur Kaser Division of Gastroenterology, Department of Medicine, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, MA, USA Richard S Blumberg You can also search for this author in PubMed Google Scholar You can also search for this author in PubMed Google Scholar Correspondence to Arthur Kaser or Richard S Blumberg. Reprints and Permissions Kaser, A., Blumberg, R. Survive an innate immune response through XBP1. Cell Res 20, 506–507 (2010). https://doi.org/10.1038/cr.2010.61 Download citation Published: 03 May 2010 Issue Date: May 2010 DOI: https://doi.org/10.1038/cr.2010.61 Genome Medicine (2018) Inflammatory Bowel Diseases (2015) Fiziolohichnyĭ zhurnal (2014) Seminars in Immunopathology (2013) Laboratory Investigation (2013)

1 June 2012 in Current Drug Delivery
Verified
Journal Article
Closed access
PDF file
AKArthur Kaser
Arthur Kaser
HTHerbert Tilg
Herbert Tilg
Mesenteric fat hypertrophy is a common feature of inflammatory bowel diseases (IBD), especially Crohn´s disease. Although this “creeping fat” has been observed in the early days of this disease, its biological relevance is not understood. This adipose tissue has been recognized to release large amounts of various cytokines such as TNFa and adipocytokines such as adiponectin or leptin. Whereas leptin is definitely a pro-inflammatory adipocytokine, the role of the prototypic anti-inflammatory adipocytokine, namely adiponectin, in intestinal inflammation is less clear. Some experimental studies suggest that it could exert also pro-inflammatory activities in the gut. An important role for metabolic aspects and potentially adipocytokines has also come from recent studies demonstrating that ATG16L1- deficient mice show a strikingly enhanced expression of both adiponectin and leptin in epithelial cells. Autophagy not only plays a key role in intestinal inflammation, but is also involved in the regulation of lipid metabolism. Another recently identified pathway in IBD, namely endoplasmic stress/XBP1, regulates fatty acid synthesis and facilitates adipogenesis and adipocyte differentiataion. Therefore, XBP1 could possibly link intestinal inflammation with the development of “creeping fat” in Crohn’s disease. Metabolic aspects have evolved as of key importance in experimental colitis and human IBD, and certain adipocytokines, autophagy, and ER stress might reflect the central players.

1 December 2004 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AKArthur Kaser
Arthur Kaser
ENEdward E. S. Nieuwenhuis
Edward E. S. Nieuwenhuis
WSWarren Strober
Warren Strober
LMLloyd Mayer
Lloyd Mayer
IFIvan Fuss
Ivan Fuss
RBRichard S. Blumberg
Richard S. Blumberg


1 July 2008 in Current Opinion in Gastroenterology
Verified
Journal Article
Closed access
AKArthur Kaser
Arthur Kaser
RBRichard S Blumberg
Richard S Blumberg
Adaptive immune mechanisms are inherently involved in the pathogenesis of inflammatory bowel disease. This review summarizes the main discoveries made in 2007 within this field. CD4 T cells secreting interleukin-17 (T helper type 17) cells have emerged as a key effector population driving colitis in animal models previously associated with exaggerated T helper type 1 responses. With regard to T-regulatory cells, a novel suppressive cytokine (interleukin-35) and induction of apoptosis as a means to exert suppression have been identified. The importance of specific chemokine receptors and integrins in effector and T-regulatory cell function in colitis has been recognized. An improved understanding of adaptive immune mechanisms, on which manifold genetic and environmental traits might converge, and which ultimately mediate intestinal inflammation in inflammatory bowel disease, holds promise for novel effective therapeutic intervention.